Cao, W <br/><br/>
CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells.  [electronic resource] 

 -  Oncogene  Sep 1997 
 - 1315-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1201305  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>Cell Differentiation<br/>DNA-Binding Proteins--drug effects<br/>Fluorescent Antibody Technique, Indirect<br/>G1 Phase--genetics<br/>Granulocyte Colony-Stimulating Factor--pharmacology<br/>Leukemia, Myelomonocytic, Acute--genetics<br/>Lymphoma--genetics<br/>Metallothionein--genetics<br/>Mice<br/>Myosins--drug effects<br/>Peroxidase--genetics<br/>Receptors, Interleukin-3--genetics<br/>Recombinant Fusion Proteins--genetics<br/>Retinoblastoma Protein--genetics<br/>S Phase--genetics<br/>Transcription Factor AP-2<br/>Transcription Factors--drug effects<br/>Zinc--pharmacology